Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary

Resource Information

The work Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary represents a distinct intellectual or artistic creation found in University of Missouri-St. Louis Libraries. This resource is a combination of several types including: Work, Language Material, Books.

Label

Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary

Title remainder

establishing an agenda for 2020 : workshop summary

Statement of responsibility

Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies

Contributor

• Institute of Medicine (U.S.), Forum on Drug Discovery, Development, and Translation
• Claiborne, Anne B
• English, Rebecca A
• Weisfeld, Neil E

Subject

• Business and medicine -- United States -- Congresses
• Clinical Trials as Topic
• Clinical trials -- Economic aspects -- United States -- Congresses
• Clinical trials -- Social aspects -- United States -- Congresses
• Clinical trials -- United States -- Congresses
• Congress
• Drug Design
• Drug Industry
• Drug development -- United States -- Congresses
• Drugs -- Testing -- Congresses
• Pharmaceutical industry -- United States -- Congresses
• Randomized Controlled Trials as Topic
• United States

Genre

• Congress
• Congresses

Language

eng

Summary

"There is growing recognition that the United States' clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired - where medical care is provided solely based on high quality evidence - and the reality - where there is limited capacity to generate timely and practical evidence for drug development and to support medical treatment decisions. With the need for transforming the CTE in the U.S. becoming more pressing, the IOM Forum on Drug Discovery, Development, and Translation held a two-day workshop in November 2011, bringing together leaders in research and health care. The workshop focused on how to transform the CTE and discussed a vision to make the enterprise more efficient, effective, and fully integrated into the health care system. Key issue areas addressed at the workshop included: the development of a robust clinical trials workforce, the alignment of cultural and financial incentives for clinical trials, and the creation of a sustainable infrastructure to support a transformed CTE. This document summarizes the workshop"--Publisher's description

Cataloging source

IDEBK

Illustrations

• illustrations
• charts

Index

no index present

Literary form

non fiction

Nature of contents

• dictionaries
• bibliography